Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022

Go back to Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 7.57 +0.16 (2.16%)
Previous Close $7.41    52 Week High $44.38 
Open $7.46    52 Week Low $24.47 
Day High $7.63    P/E 378.50 
Day Low $7.35    EPS $0.02 
Volume 224,166